253 results on '"Belyakov, Igor M"'
Search Results
2. Shared Modes of Protection against Poxvirus Infection by Attenuated and Conventional Smallpox Vaccine Viruses
3. Late Effects of the Chernobyl Radiation Accident on T Cell-Mediated Immunity in Cleanup Workers
4. A Push-Pull Approach to Maximize Vaccine Efficacy: Abrogating Suppression with an IL-13 Inhibitor While Augmenting Help with Granulocyte/Macrophage Colony-Stimulating Factor and CD40L
5. Prophylactic DNA Vaccine for Hepatitis C Virus (HCV) Infection: HCV-Specific Cytotoxic T Lymphocyte Induction and Protection from HCV-Recombinant Vaccinia Infection in an HLA-A2.1 Transgenic Mouse Model
6. Mucosal Vaccination Overcomes the Barrier to Recombinant Vaccinia Immunization Caused by Preexisting Poxvirus Immunity
7. Mucosal Immunization with HIV-1 Peptide Vaccine Induces Mucosal and Systemic Cytotoxic T Lymphocytes and Protective Immunity in Mice against Intrarectal Recombinant HIV-Vaccinia Challenge
8. The use of electroporation to deliver DNA-based vaccines.
9. Mucosal Immunity and HIV-1 Infection: Applications for Mucosal AIDS Vaccine Development
10. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques
11. Toll-Like Receptor Ligands Synergize through Distinct Dendritic Cell Pathways to Induce T Cell Responses: Implications for Vaccines
12. TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4 + memory T cell loss in SIVmac251-challenged rhesus macaques
13. Memories that last forever: strategies for optimizing vaccine T-cell memory
14. Molecular pathways regulating CD4 + T cell differentiation, anergy and memory with implications for vaccines
15. Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS
16. Modeling a Safer Smallpox Vaccination Regimen, for Human Immunodeficiency Virus Type 1-Infected Patients, in Immunocompromised Macaques
17. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines
18. Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
19. The IL-15 receptor α chain cytoplasmic domain is critical for normal IL-15Rα function but is not required for trans-presentation
20. Functional CD8 + CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine
21. Generation of functionally active HIV-1 specific CD8 + CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization
22. Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA
23. Estimation of low frequency antigen-presenting cells with a novel RELISPOT assay
24. Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development
25. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice
26. Novel approaches in polyepitope T-cell vaccine development against HIV-1
27. Mucosal Immunity and HIV-1 Infection: Applications for Mucosal AIDS Vaccine Development
28. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
29. Strategies for designing and optimizing new generation vaccines
30. Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa
31. Improved SIV DNA vaccine can be effectively used as a boost for Ad5 in prime–boost immunization strategy
32. Can Vaccine-induced Mucosal High Avidity CD8+ CTL Delay AIDS-viral Dissemination from Mucosa?
33. Role of α3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs
34. Avidity of CD8 T cells sharpens immunodominance
35. Immunobiology of Mucosal HIV Infection and the Basis for Development of a New Generation of Mucosal AIDS Vaccines
36. Mucosal AIDS vaccines: current status and future directions
37. Progress on new vaccine strategies against chronic viral infections
38. Progress on new vaccine strategies for the immunotherapy and prevention of cancer
39. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells
40. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?
41. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection
42. Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression: IL-12 and tumor necrosis factor-α synergize for IL-12R expression at low antigen dose
43. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge
44. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections
45. The Importance of Local Mucosal HIV-Specific CD8+ Cytotoxic T Lymphocytes for Resistance to Mucosal Viral Transmission in Mice and Enhancement of Resistance by Local Administration of IL-12
46. DNA vaccines encoding human immunodeficiency virus–1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses
47. Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development
48. Multiple Antigen Peptide Vaccines against Plasmodium falciparum Malaria
49. Novel approaches in polyepitope T-cell vaccine development against HIV-1
50. Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+ and CD8+ T Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.